Unapproved drug prescribed for cases of extreme morning sickness is now being blamed for birth defects.
Yesterday, the Toronto Star reported that an unapproved anti-nausea drug used for morning sickness is linked to birth defects. The drug—ondansetron—is being prescribed by doctors for Hyperemesis gravidarum (the kind of extreme morning sickness that Kate Middleton had). Ondansetron is approved by Health Canada for chemotherapy patients; yet, it has not been given the go-ahead to treat pregnant women. However, some doctors have been prescribing the drug "off label" to help expectant moms handle cases of extreme vomiting.
The Star went through reports from the US-based Food and Drug Administration (FDA) and found that at least 20 pregnant Canadian women treated with ondansetron experienced side effects, including two infant deaths and multiple cases of babies born with heart and kidney defects.
According to the Star:
This is scary news for women who have already taken the drug, or who are so sick that doctors prescribe it as a last resort. A mother quoted in the Star said that it was the only thing that stopped her constant vomiting. Luckily, her daughter did not have any side effects, but she says that she would take it again because it was the only thing that got her through her pregnancy.
Read more: The facts of morning sickness>
Ondansetron is not related to Diclectin (doxylamine-pyridoxine), which is approved by Health Canada for nausea during pregnancy and does not have any known side effects.
Did you take a drug to ease your vomiting and nausea while pregnant?
Emma Waverman is a writer, blogger and mom to three kids. She has many opinions, some of them are fit to print. Read more of her articles here and follow her on Twitter @emmawaverman.
Keep up with your baby's development, get the latest parenting content and receive special offers from our partners
Emma Waverman is a writer, blogger and mom to three kids. She has many opinions, some of them fit to print. Read more of her articles here and follow her on Twitter @emmawaverman.